Genomic evidence of pre-invasive clonal expansion, dispersal and progression in bronchial dysplasia

Journal of Pathology

Volumn 224, Issue 2, 2011, Pages 153-159

  McCaughan, Frank ^a   Pipinikas, Christodoulos P ^b   Janes, Sam M ^b   George, P Jeremy ^b   Rabbitts, Pamela H ^c   Dear, Paul H ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

bronchial dysplasia; clonality; molecular copy number counting

Indexed keywords

AMPLICON; ARTICLE; BRONCHUS DISEASE; BRONCHUS DYSPLASIA; CARCINOGENESIS; CASE REPORT; CLONAL VARIATION; GENE AMPLIFICATION; GENOMICS; HUMAN; LUNG CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; BIOPSY; BRONCHI; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; GENOMICS; HUMANS; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MICRODISSECTION; NEOPLASTIC STEM CELLS; PRECANCEROUS CONDITIONS;

EID: 79955789430     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2887     Document Type: Article

References (27)

1. Slaughter DP, Southwick HW, Smejkal W,. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-968.
2. Braakhuis BJ, Tabor MP, Kummer JA, et al., A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727-1730. (Pubitemid 36460827)
3. Braakhuis BJ, Leemans CR, Brakenhoff RH,. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol 2005; 15: 113-120. (Pubitemid 40126242)
4. Gazdar AF, Minna JD,. Multifocal lung cancersâclonality vs field cancerization and does it matter? J Natl Cancer Inst 2009; 101: 541-543.
5. Chung GT, Sundaresan V, Hasleton P, et al., Clonal evolution of lung tumors. Cancer Res 1996; 56: 1609-1614. (Pubitemid 26104025)
6. Banerjee AK, Read CA, Griffiths MH, et al., Clonal divergence in lung cancer development is associated with allelic loss on chromosome 4. Genes Chromosomes Cancer 2007; 46: 852-860. (Pubitemid 47106189)
7. Foster NA, Banerjee AK, Xian J, et al., Somatic genetic changes accompanying lung tumor development. Genes Chromosomes Cancer 2005; 44: 65-75. (Pubitemid 41060197)
8. Wistuba II, Behrens C, Milchgrub S, et al., Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999; 18: 643-650. (Pubitemid 29080321)
9. Wistuba II, Behrens C, Virmani AK, et al., High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000; 60: 1949-1960. (Pubitemid 30207657)
10. Leedham SJ, Wright NA,. Human tumour clonality assessmentâflawed but necessary. J Pathol 2008; 215: 351-354.
11. Franklin WA, Gazdar AF, Haney J, et al., Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 1997; 100: 2133-2137. (Pubitemid 27459370)
12. Wang X, Wang M, MacLennan GT, et al., Evidence for common clonal origin of multifocal lung cancers. J Natl Cancer Inst 2009; 101: 560-570.
13. McCaughan F, Darai-Ramqvist E, Bankier AT, et al., Microdissection molecular copy-number counting (microMCC)âunlocking cancer archives with digital PCR. J Pathol 2008; 216: 307-316.
14. McCaughan F, Pole JC, Bankier AT, et al., Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer. Am J Respir Crit Care Med 2010; 182: 83-91.
15. Bass AJ, Watanabe H, Mermel CH, et al., SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 2009; 41: 1238-42.
16. Hussenet T, Dali S, Exinger J, et al., SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One 2010; 5: e8960.
17. George PJ, Banerjee AK, Read CA, et al., Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax 2007; 62: 43-50. (Pubitemid 46101765)
18. Liu W, Laitinen S, Khan S, et al., Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009; 15: 559-565.
19. Bollet MA, Servant N, Neuvial P, et al., High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers. J Natl Cancer Inst 2008; 100: 48-58. (Pubitemid 351767338)
20. Letouze E, Allory Y, Bollet MA, et al., Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis. Genome Biol 2010; 11: R76.
21. Wood HM, Belvedere O, Conway C, et al., Using next-generation sequencing for high-resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens. Nucleic Acids Res 2010; 38: e151.
22. Navin N, Krasnitz A, Rodgers L, et al., Inferring tumor progression from genomic heterogeneity. Genome Res 2010; 20: 68-80.
23. Daser A, Thangavelu M, Pannell R, et al., Interrogation of genomes by molecular copy-number counting (MCC). Nat Methods 2006; 3: 447-453. (Pubitemid 43811556)
24. Forbes SA, Tang G, Bindal N, et al., COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 2009.
25. Bignell GR, Santarius T, Pole JC, et al., Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res 2007; 17: 1296-1303. (Pubitemid 47360904)
26. Merlo LM, Shah NA, Li X, et al., A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev Res (Philadelphia) 2010; 3: 1388-1397.
27. Qian J, Massion PP,. Role of chromosome 3q amplification in lung cancer. J Thorac Oncol 2008; 3: 212-215. (Pubitemid 351654319)